Genomics & Personalised Medicine

Your genome contains roughly three billion base pairs of DNA, and making sense of that information is one of the most data-intensive challenges in science. AI is accelerating genomics research by identifying patterns in genetic data that correlate with disease risk, drug response, and treatment outcomes. The vision of personalised medicine - treatments tailored to your individual genetic profile - has been discussed for decades, but AI is making it increasingly practical. Cancer treatment has seen the most progress. AI systems can analyse tumour genetics to identify which mutations are driving the disease and predict which treatments are most likely to be effective for a specific patient. Pharmacogenomics uses genetic information to predict how you will respond to particular drugs, helping doctors choose the right medication at the right dose and avoid adverse reactions. The challenges are substantial. Genetic data is incredibly complex, and the relationship between genes and health outcomes is influenced by environment, lifestyle, and interactions between thousands of genes. Most genomic research has been conducted predominantly on populations of European descent, which means AI models trained on this data may perform poorly for other populations. The promise of personalised medicine is real, but it remains a work in progress rather than a finished revolution.